Jumei Shi Selected Research

Jumei Shi Research Topics

Disease

35	Multiple Myeloma 12/2023 - 02/2008
32	Neoplasms (Cancer) 04/2024 - 02/2008
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 11/2015
7	Lymphoma (Lymphomas) 02/2024 - 05/2016
5	T-Cell Leukemia (Leukemia, T Cell) 06/2020 - 06/2014
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 11/2016
3	B-Cell Lymphoma (Lymphoma, B Cell) 06/2020 - 06/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2018 - 08/2018
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2015 - 06/2014
2	Leukemia 06/2014 - 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2023
1	Carcinogenesis 09/2023
1	Tics (Tic) 01/2020
1	Pathologic Complete Response 01/2020
1	Residual Neoplasm 01/2020
1	Thrombosis (Thrombus) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Fascioliasis 01/2019
1	Chromosomal Instability (Chromosome Stability) 04/2017
1	Venous Thromboembolism 08/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2016
1	Proteinuria 01/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2015
1	Smoldering Multiple Myeloma 01/2015
1	Fatigue 01/2014
1	Constipation 01/2014

Drug/Important Bio-Agent (IBA)

6	Bortezomib (Velcade)FDA Link 11/2023 - 02/2008
6	pterostilbeneIBA 04/2020 - 11/2016
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2013
5	Proteasome InhibitorsIBA 09/2023 - 02/2008
4	DCZ3301IBA 06/2020 - 01/2017
4	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2014
4	LigandsIBA 04/2013 - 12/2008
3	DCZ0358IBA 12/2023 - 01/2018
3	PanobinostatIBA 01/2020 - 01/2015
3	carfilzomibIBA 05/2016 - 06/2014
2	ResveratrolIBA 05/2021 - 11/2016
2	SiliconesIBA 01/2021 - 01/2020
2	RafoxanideIBA 02/2020 - 01/2019
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 12/2008
2	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2020 - 04/2017
2	IronIBA 01/2019 - 06/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2018 - 01/2018
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 08/2018 - 11/2016
2	Matrix Metalloproteinases (MMPs)IBA 07/2018 - 06/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2016 - 06/2014
2	Vorinostat FDA Link 05/2016 - 06/2014
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2014 - 02/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Cantharidin (Cantharides)IBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 12/2023
1	Pain-FreeIBA 12/2023
1	norcantharidinIBA 11/2023
1	bafilomycin A1IBA 10/2023
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 09/2023
1	ribosomal protein S3IBA 09/2023
1	AlkaloidsIBA 02/2023
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 05/2022
1	FlavonoidsIBA 11/2021
1	QuercetinIBA 11/2021
1	LuciferasesIBA 05/2021
1	osalmideIBA 04/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020
1	Therapeutic UsesIBA 01/2020
1	ruxolitinibIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Type III Secretion SystemsIBA 01/2019
1	metal transporting protein 1 (ferroportin)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	InflammasomesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 08/2018
1	sotrastaurinIBA 04/2018
1	Cytotoxins (Cytolysins)IBA 10/2017
1	Rituximab (Mabthera)FDA Link 06/2017
1	Dobutamine FDA LinkGeneric 12/2016
1	MitogensIBA 12/2016
1	Protein Kinases (Protein Kinase)IBA 11/2016
1	AntioxidantsIBA 11/2016
1	JNK Mitogen-Activated Protein KinasesIBA 11/2016
1	Thalidomide (Thalomid)FDA Link 08/2016
1	fucoidanIBA 11/2015
1	CateninsIBA 02/2015
1	ibrutinibIBA 02/2015
1	CGI 1746IBA 02/2015
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2015
1	Immunoglobulin A (IgA)IBA 01/2015
1	HLA-G Antigens (HLA G)IBA 07/2014
1	Cytochromes c (Cytochrome c)IBA 06/2014
1	Caspase 9IBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014

Therapy/Procedure

13	Therapeutics 12/2023 - 01/2015
4	Intraperitoneal Injections 04/2020 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2018
2	Stem Cell Transplantation 06/2017 - 01/2014
1	Heterologous Transplantation (Xenotransplantation) 05/2019
1	Radiotherapy 06/2017
1	Intravenous Administration 11/2016
1	Oral Administration 11/2015
1	Hematopoietic Stem Cell Transplantation 01/2015